ALSO NOTED: Appeals court votes for FDA approval shield; Suicides rose as depression treatment fell;

> A federal appeals court backed the drug industry's arguments that it should be insulated from lawsuits over FDA-approved products, ruling 2-1 that antidepressant makers GlaxoSmithKline and Pfizer could not be held liable for the suicides of two patients using SSRIs. Report [1]

> A new study shows rising suicide rates among children and teens in Canada, two years after drug regulators there warned of the safety risks of antidepressant use in children; the climbing suicide rate coincided with a 10 percent drop in the rate of doctor visits for depression treatment among children. Report [2]

> Galderma Pharma has wrapped up its $420 million tender offer for fellow dermatology drug company CollaGenex Pharmaceuticals. Report [3]

> Louisiana's new attorney general withdrew a multimillion-dollar antitrust lawsuit filed against Amgen by his predecessor. Report [4]

> The healthcare and IT company McKesson has agreed to pay $190 million for McQueary Brothers Drug Co., a pharma and beauty products distributor based in Springfield, Mo. Report [5]

> Novartis' plans to erect three wind turbines on its Grimsby, England, campus have drawn fire from environmentalists worried that the huge windmills might disturb birds. Report [6]

> India's Dabur Pharma has agreed to supply Thailand with a copycat form of Sanofi-Aventis' Taxotere, which the Thai government is importing under a patent-busting compulsory license. Report [7]

> Estrogen-only hormone replacement therapy has been linked to a benign breast-lump disease that's often a precursor to cancer. Report [8]

> There's a shakeup under way at Inotek. The Beverly, MA-based developer says it is closing several international sites and a pilot manufacturing facility in Israel as it focuses all of its efforts on its two main programs and two preclinical programs. Report [9]

> Endo Pharmaceuticals says a close reading of a non-approvable letter from the FDA for Frova prompted officials to pull their request to gain approval for the short-term relief of menstrual migraine. Report [10]

> Scientists at Memorial Sloan-Kettering Cancer Center in New York City have identified the molecular process by which breast cancer cells spread to other tissue during metastasis. Report [11]

And Finally... Russia has improbably emerged as a world leader in new cancer vaccines. The country's regulatory body approved the use of Antigenics' new kidney cancer vaccine, Oncophage--a world first. Report [12]